The European Patent Office (EPO) has granted patent EP3612195B1, titled "A METHOD OF STIMULATING ASYMMETRIC DIVISION OF SATELLITE STEM CELLS." This patent, effective March 18, 2026, relates to advancements in biotechnology and specifically targets methods for stimulating satellite stem cell division. The patent lists Michael Rudnicki, Yu Wang, and Xin Wang as inventors and covers various International Patent Classification (IPC) codes including A61K, A61P, C07K, and C12N.

This grant represents a new intellectual property right for the inventors and their associated entities. While this is a patent grant and not a regulatory rule imposing direct compliance obligations on companies, it signifies a new technological development in the biotech sector. Companies operating in regenerative medicine, cell therapy, or related research areas should be aware of this patent, particularly if their activities involve satellite stem cell manipulation, to ensure they do not infringe on the granted claims. No immediate compliance actions are required by this patent grant itself, but it may influence future research and development strategies and licensing considerations.